We serve Chemical Name:2,3-Dihydro-1,4-benzodithiin CAS:6247-55-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,3-Dihydro-1,4-benzodithiin
CAS.NO:6247-55-8
Synonyms:2,3-dihydro-1,4-benzodithiine
Molecular Formula:C8H8S2
Molecular Weight:168.27900
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:269.1ºC at 760 mmHg
Density:1.244 g/cm3
Index of Refraction:1.663
PSA:50.60000
Exact Mass:168.00700
LogP:2.88440
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2,3-dihydro-1,4-benzodithiine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-dihydro-1,4-benzodithiine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-dihydro-1,4-benzodithiine Use and application,2,3-dihydro-1,4-benzodithiine technical grade,usp/ep/jp grade.
Related News: After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. 2,3-Dihydro-1,4-benzodithiin manufacturer By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names. 2,3-Dihydro-1,4-benzodithiin supplier Active pharmaceutical ingredients directly impact disease. 2,3-Dihydro-1,4-benzodithiin vendor Active pharmaceutical ingredients directly impact disease. 2,3-Dihydro-1,4-benzodithiin factory After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.
